Pharmaceutical Commerce - November/December 2014

Regulatory compliance continues to exceed cost as a primary driver

A big jump in 2012-2013 venture funding will fuel growth; BMS' new facility

Airport will organize client carriers to meet new IATA standards

Tracking systems dominate product introductions

Company is part of limited distribution for a Lundbeck neurologic treatment

Payer trends dominate near-term outlook

Efforts to align drug wholesaling business with manufacturer services

GS1 Healthcare US publishes updated track-and-trace guidance; vendors revamp their offerings

Largest independent specialty pharmacy rides specialty-pharma wave

Vendor-managed system inventories and protects specialty pharmaceuticals in healthcare settings

DHL garners headlines with a 'parcelcopter' delivering daily drugs to remote North Sea island

Often, needless cost and complexity--without improving quality and safety--impede cold chain packaging planning

Pharma companies will need to do more than rely on pharmacies' adjudication of claims

Some state-level changes give an indication of what to prepare for

An 'expectations convergence' is building in how drug efficacy aligns with patient outcomes

Contracts with payers that contain terms based on outcomes can highlight a drug's value

Service providers are building out a wider range of services to meet drug developers' needs

More complex products and higher risk are changing the nature of pharmaceutical outsourcing

As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize